Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
teva ceo News and latest stories | The Jerusalem Post
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
In letter to Israeli PM, Teva CEO apologizes for drug-maker's sorry state | The Times of Israel
Teva CEO on decimated share price: "It's rational enough from a market point of view" — MedWatch
Teva chooses new CEO
Teva CEO Exits Amid Crisis of Confidence at Drugmaker
Teva CEO reportedly wanted to stay in his job | The Times of Israel
Teva Pharmaceutical CEO Talks Opioids, Lawsuits, and the Long Road Ahead | Barron's
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Teva CEO Kare Schultz on coronavirus treatment and a possible second wave
Teva Execs Topped TASE's High Earners List for 2018 | Ctech
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Schultz kept Teva away from the abyss, but couldn't find a runway to growth | Ctech
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | Fierce Pharma
Teva Announces Appointment of Richard Francis as President and CEO | Business Wire
Five Things Facing Teva's New CEO Richard Francis :: Generics Bulletin
Teva Pharmaceuticals on Twitter: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay
New Teva CEO reorganizes with an 'ax, not hedge clippers or pruning shears' - STAT
Teva CEO: 'Content' With 2/3 Access of Payers for Migraine Drug Ajovy
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
